R&D

Can we really regenerate the human body from head to toe?

Can we really regenerate the human body from head to toe?

Written by on November 24, 2014 in Featured on app, Research & Development with 0 Comments

As news hits the stand that next May will see the ‘world’s first 3D-bioprinted organ transplantation’ take place with a thyroid gland, we take a look at a selection of other regeneration projects from across the globe that are working towards regenerating parts of the human body ahead of the tissue engineering and organ regeneration […]

Continue Reading

Can cell therapy become the next generation of biological therapeutic products?

Can cell therapy become the next generation of biological therapeutic products?

Written by on November 22, 2014 in Regenerative Medicine, Research & Development with 0 Comments

Zami Aberman, Chairman and Chief Executive Officer, Pluristem joined us at the 9th Annual World Stem Cells & Regenerative Medicine Congress to present ‘Can cell therapy become the next generation of biological therapeutic product?’ Download this presentation now to find out: Can cell therapy become the next generation of biological therapeutic products? Cell therapy “must haves” […]

Continue Reading

Drug Discovery

Landsteiner Scientific Discute los Biocomparables y la Medicina Genómica

Landsteiner Scientific Discute los Biocomparables y la Medicina Genómica

Written by on October 27, 2014 in Drug Discovery, Reports, Research & Development with 0 Comments

Francisco Kuri Breña, Director de Nuevos Desarrollos a Landsteiner Scientific, fue ponente al evento BioPharma México, del año pasado, donde dió una presentación en los biocomparables y la medicina genómica. Francisco ha trabajado en el desarrollo de nuevos productos sintéticos y biotecnológicos así como en proyectos de medicina genómica en la misma empresa. Realizó estudios […]

Continue Reading

Could Antibodies Provide the Answer to Curing Ebola?

Could Antibodies Provide the Answer to Curing Ebola?

Written by on October 17, 2014 in Drug Discovery with 1 Comment

Newly discovered antibody drugs such as ZMAPP could provide a solution to the Ebola epidemic that’s sweeping across the globe. We have known about the capacity of antibodies for modulating the immune system for decades, and there are already hundreds of antibody-based drugs that are used to effectively fight various illnesses such as cancer and […]

Continue Reading

Clinical Trials

Infographic: Integrating new technology and processes to accelerate drug development

Infographic: Integrating new technology and processes to accelerate drug development

Written by on November 27, 2014 in Clinical Trials with 0 Comments

We’ve recently introduced new formats and new innovative ways to demonstrate the content given at our conferences. One of the latest introductions is the use of graphic reporting at our conferences. What’s a graphic reporter? A graphic reporter is someone who creates infographics concurrently with a presenter at the event – kind of like an […]

Continue Reading

Ebook: Clinical Innovation – The story so far… in pictures

Ebook: Clinical Innovation – The story so far… in pictures

Written by on November 25, 2014 in Clinical Trials with 0 Comments

  We’ve recently introduced new formats and new innovative ways to demonstrate the content given at our conferences. One of the latest introductions is the use of graphic reporting. What’s a graphic reporter? A graphic reporter is someone who creates infographics concurrently with a presenter at the event – kind of like an interpreter, but with pictures. […]

Continue Reading

Manufacturing

Who are the top 4 Players in 3D Antibody Characterization?

Who are the top 4 Players in 3D Antibody Characterization?

Written by on November 25, 2014 in Antibodies, Manufacturing with 0 Comments

Who are the top 4 Players in 3D Antibody Characterization? Therapeutic antibody engineering has been around for years. So what is keeping the number of therapeutic antibody treatments so relatively low when compared to small molecules and other types of therapeutics? Antibodies, and their therapeutic derivatives such as antibody-drug conjugates (ADCs), are complex, multi-faceted molecules […]

Continue Reading

Enabling Cell Therapy: Case Study on Scaling-Up Allogeneic Stem Cell Manufacturing From Multi-Tray Stacks To the Xpansion® MultiplateBioreactor

Enabling Cell Therapy: Case Study on Scaling-Up Allogeneic Stem Cell Manufacturing From Multi-Tray Stacks To the Xpansion® MultiplateBioreactor

Written by on November 24, 2014 in Manufacturing, Regenerative Medicine with 0 Comments

Sarah Snykers and Dr. Jose Castillo, Pall Life Sciences joined us at the 9th Annual World Stem Cells & Regenerative Medicine Congress to discuss ‘Enabling Cell Therapy: Case Study on Scaling-Up Allogeneic Stem Cell Manufacturing From Multi-Tray Stacks To the Xpansion® MultiplateBioreactor.’ Download this presentation now to find out: Promethera® Biosciences • Who we are? […]

Continue Reading

Regulation & Compliance

Implementing an Enterprise Wide LMS

Implementing an Enterprise Wide LMS

Some time back, not too long ago, the North American headquarters of a global Pharmaceutical company acquired several business units, and in an effort to standardize roles and consolidate training and qualifications, company leaders were seeking a single Learning Management System (LMS) to unify its eight operating companies and 7,000 employees. Leading the LMS evaluation […]

Continue Reading

Private Cord Blood Banks vs Public Health: Is it Time to Bury the Hatchet?

Private Cord Blood Banks vs Public Health: Is it Time to Bury the Hatchet?

Written by on October 27, 2014 in Regulation and Compliance with 0 Comments

Can private cord blood banks ever work in synergy with public and national health services? Cord blood is the blood that remains in the placenta and umbilical cord after a baby is born. It is rich in stem cells, which can help to cure many life threatening diseases. The stem cells found in cord blood […]

Continue Reading

Pricing & Market Access

From promise to reality: how is real world evidence shaping the future of healthcare?

From promise to reality: how is real world evidence shaping the future of healthcare?

Written by on November 22, 2014 in Pricing & Market Access, Reports with 0 Comments

At Evidence EU  2014, David Haslam, Chairman NICE gave a presentation on “From promise to reality: how is real world evidence shaping the future of healthcare?” This presentation explores NICE’s role in improving outcomes for people as well as focusing on challenges (uptake, implementation and pushy patients) and value-based assessment. Download and learn: The multi […]

Continue Reading

Latest results of early benefit assessments and price negotiations

Latest results of early benefit assessments and price negotiations

Written by on November 15, 2014 in Pricing & Market Access, Reports with 0 Comments

At Pharma Pricing 2014, Meriem Bouslouk PhD, Pharmaceuticals Department, Federal Joint Committee Germany gave a presentation “Latest results of early benefit assessments and price negotiations” Download and learn: Assessment principles- Key points Consultations with the G-BA Orphan Drugs Price negotiations / Arbitration Decisions / OPT-OUTS G-BA vision at European level Licensing and reimbursing: harmonization? Download presentation […]

Continue Reading

Engagement & Marketing

New Age Project Management

New Age Project Management

Traditionally, Project Management was all about cost, timeline and success of that project. But most often than not, there are dependencies for a project – either upstream or downstream. These dependencies become all the more important when (mostly when and not if) the project deviates from cost ortimeline. On what basis should the decision makers tasked with bringing back the […]

Continue Reading

3 ways to use social media as a healthcare professional

3 ways to use social media as a healthcare professional

Written by on October 24, 2014 in Engagement & Communications, Featured on app with 0 Comments

Whether you are a healthcare clinician or patient, biotech CEO or an academic professor, there is a social media platform for you. Those who know me will know that I am a big advocate of using different social media platforms to engage with your communities. That said, what can be deemed as productive can often […]

Continue Reading

Partnering & Investment

Promising scale and market success for cell therapies after large financial injection

Promising scale and market success for cell therapies after large financial injection

Written by on September 19, 2014 in Featured on app, Partnering & Investment with 0 Comments

In a report released this week, by BCC Research, it was forecasted that the global market for stem cells (including cell therapies) is to reach US $10.6 billion in 2018. However with currently no medicines, based on stem cells, having yet received marketing authorisation from the EMA*, or the FDA*, how are we going to get there? […]

Continue Reading

An investor perspective and analysis of the stem cell & regenerative medicine sector

An investor perspective and analysis of the stem cell & regenerative medicine sector

Written by on September 12, 2014 in Partnering & Investment, Regenerative Medicine with 0 Comments

Dr. Navid Malik B.Sc. M.Sc. MBA, Cenkos joined us at the 9th Annual World Stem Cells & Regenerative Medicine Congress to present on ‘An investor perspective and analysis of the stem cell & regenerative medicine sector’ Download this presentation now to find out: Cenkos Securities’ focus on Life Sciences Longer-term sector returns have been very […]

Continue Reading

Top
Geolocation